Search

Your search keyword '"Cortis, E."' showing total 157 results

Search Constraints

Start Over You searched for: Author "Cortis, E." Remove constraint Author: "Cortis, E."
157 results on '"Cortis, E."'

Search Results

1. Musculoskeletal manifestations of childhood cancer and differential diagnosis with juvenile idiopathic arthritis (ONCOREUM): a multicentre, cross-sectional study

2. Musculoskeletal manifestations of childhood cancer and differential diagnosis with juvenile idiopathic arthritis (ONCOREUM): a multicentre, cross-sectional study

3. Transitional care management in patients with auto-inflammatory diseases: experience of cooperation of a paediatric and adult centre

4. Impact of novel coronavirus Disease-19 (COVID-19) pandemic in Italian pediatric emergency departments: a national survey

6. Musculoskeletal manifestations of childhood cancer and differential diagnosis with juvenile idiopathic arthritis (ONCOREUM): a multicentre, cross-sectional study

7. Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease.

13. Differences in therapeutic approach to juvenile dermatomyositis between Europe and Latin America

18. Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis

22. Strategies for preventing group B streptococcal infections in newborns: A nation-wide survey of Italian policies

23. Correction to: The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) (Rheumatology International, (2018), 38, S1, (251-258), 10.1007/s00296-018-3960-1)

24. Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase

25. Kawasaki disease: guidelines of the Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks

26. The Italian version of the juvenile arthritis multidimensional assessment report (JAMAR)

27. Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

28. EVALUATION OF THE DISEASE COURSE OF ITALIAN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS TREATED WITH ETANERCEPT: PRELIMINARY RESULTS IN 1019 PATIENTS

30. Treatment with etanercept in 1019 Italian children with juvenile idiopathic arthriti: preliminary results

31. Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept.

32. Predictors of outcome in Juvenile Polyarteritis Nodosa: a multi-center study

33. Therapeutic Approaches for the Treatment of New Onset and Flared Juvenile Systemic Lupus Erythematosus with Active Renal Disease: An International Multicenter PRINTO Study

34. Abatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritis

35. Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial

36. The validated printo core set and definition of improvement for juvenile myositis

42. AB1020 Evaluation of the Disease Course of Italian Children with Juvenile Idiopathic Arthritis Treated with Etanercept: Preliminary Results in 1019 Patients

44. Clinical overview and outcome in a cohort of children with polyarteritis nodosa

45. Preliminary evidence that etanercept may reduce radiographic progression in juvenile idiopathic arthritis

46. The PRINTO criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus. Prospective validation of the definition of improvement

Catalog

Books, media, physical & digital resources